HEMOGLOBINOPATHY
Clinical trials for HEMOGLOBINOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEMOGLOBINOPATHY trials appear
Sign up with your email to follow new studies for HEMOGLOBINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy patients monitored for 15 years in landmark sickle cell study
Disease control Recruiting nowThis study follows 50 people with sickle cell disease who received a gene therapy called BEAM-101. Researchers will check for side effects and monitor health for up to 15 years after treatment. The goal is to understand long-term safety and how well the therapy controls the disea…
Matched conditions: HEMOGLOBINOPATHY
Sponsor: Beam Therapeutics Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
How long do red blood cells live? new study aims to find out
Knowledge-focused Recruiting nowThis study measures how long red blood cells survive in people with sickle cell disease and other inherited blood disorders. Researchers will label participants' own red blood cells with biotin (a vitamin) and track them over time. The goal is to compare cell survival between tho…
Matched conditions: HEMOGLOBINOPATHY
Phase: EARLY_PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC